Dietary sodiumintake regulates angiotensin II type 1, mineralocorticoid receptor, and associated signaling proteins in heart

Journal of Endocrinology

Volumn 211, Issue 1, 2011, Pages 47-54

  Ricchiuti, Vincent ^a   Lapointe, Nathalie ^a   Pojoga, Luminita ^a   Yao, Tham ^a   Tran, Loc ^a   Williams, Gordon H ^a   Adler, Gail K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CAVEOLIN 1; CAVEOLIN 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DIET RESTRICTION; DIETARY INTAKE; HEART FUNCTION; HEART INJURY; HYPOTHESIS; IMMUNOPRECIPITATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SODIUM INTAKE; WESTERN BLOTTING; ANIMAL; DOSE RESPONSE; DRUG EFFECT; HEART; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WISTAR RAT;

ANIMALS; CAVEOLIN 1; CAVEOLIN 3; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; MALE; MODELS, ANIMAL; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, MINERALOCORTICOID; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; SODIUM, DIETARY;

EID: 80555157695     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-10-0458     Document Type: Article

References (32)

1. Aguilera G & Catt K 1981 Regulation of vascular angiotensin II receptors in the rat during altered sodium intake. Circulation Research 49 751-758.
2. Aguilera G, Harwood JP & Catt KJ 1981 Somatostatin modulates effects of angiotensin II in adrenal glomerulosa zone. Nature 292 262-263. (doi:10.1038/292262a0)
3. Bader M, Peters J, Baltatu O, Müller DN, Luft FC & Ganten D 2001 Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. Journal of Molecular Medicine 79 76-102. (doi:10.1007/s001090100210)
4. Bellucci A & Wilkes BM 1984 Mechanism of sodium modulation of glomerular angiotensin receptors in the rat. Journal of Clinical Investigation 74 1593-1600. (doi:10.1172/JCI111575)
5. Benard L, Milliez P, Ambroisine M, Messaoudi S, Samuel J & Delcayre C 2009 Effects of aldosterone on coronary function. Pharmacological Reports 61 58-66.
6. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG & Shaul PW 2000 Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circulation Research 87 e44.
7. Doi R, Masuyama T, Yamamoto K, Doi Y, Mano T, Sakata Y, Ono K, Kuzuya T, Hirota S, Koyama Tet al. 2000 Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in dahl saltsensitive rats. Journal of Hypertension 18 111-120. (doi:10.1097/00004872-200018010-00016)
8. Dzau VJ 1987 Implications of local angiotensin production in cardiovascular physiology and pharmacology. American Journal of Cardiology 59 59A-65A. (doi:10.1016/0002-9149(87)90178-0)
9. Garg R & Adler GK 2009 Aldosterone and its cardiovascular effects. In Textbook of Nephro-Endocrinology. Eds AK Singh & GH Williams. Elsevier Science Publishers.
10. Gomez-Sanchez CE, de Rodriguez AF, Romero DG, Estess J, Warden MP, Gomez-Sanchez MT & Gomez-Sanchez EP 2006 Development of a panel of monoclonal antibodies against the mineralocorticoid receptor. Endocrinology 147 1343-1348. (doi:10.1210/en.2005-0860)
11. Guo C, Martinez-Vasquez D, Mendez GP, Toniolo MF, Yao TM, Oestreicher EM, Kikuchi T, Lapointe N, Pojoga L, Williams GH et al. 2006 Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus. Endocrinology 147 5363-5373. (doi:10.1210/en.2006-0944)
12. Johansson ME, Bernberg E, Andersson IJ, Bie P, Skøtt O, Gan LM & Bergström G 2009 High-salt diet combined with elevated angiotensin II accelerates atherosclerosis in apolipoprotein E-deficient mice. Journal of Hypertension 27 41-47. (doi:10.1097/HJH.0b013e328318697b)
13. Klinge CM, Wickramasinghe NS, Ivanova MM & Dougherty SM 2008 Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB Journal 22 2185-2197. (doi:10.1096/fj.07-103366)
14. Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME & Karas RH 2004 Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha. PNAS 101 17126-17131. (doi:10.1073/pnas.0407492101)
15. Pojoga LH, Romero JR, Yao TM, Loutraris P, Ricchiuti V, Coutinho P, Guo C, Lapointe N, Stone JR, Adler GK et al. 2010 Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II. Endocrinology 151 1236-1246. (doi:10. 1210/en.2009-0514)
16. Marney AM & Brown NJ 2007 Aldosterone and end-organ damage. Clinical Science 113 267-278. (doi:10.1042/CS20070123)
17. Martinez DV, Rocha R, Matsumura M, Oestreicher E, Ochoa-Maya M, Roubsanthisuk W, Williams GH & Adler GK 2002 Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. Hypertension 39 614-618.
18. Oestreicher EM, Martinez-Vasquez D, Stone JR, Jonasson L, Roubsanthisuk W, Mukasa K & Adler GK 2003 Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury. Circulation 108 2517-2523. (doi:10.1161/01.CIR.0000097000.51723.6F)
19. Oestreicher EM, Guo C, Seely EW, Kikuchi T, Martinez-Vasquez D, Jonasson L, Yao T, Burr D, Mayoral S, Roubsanthisuk Wet al. 2006 Estradiol increases proteinuria and angiotensin II type 1 receptor in kidneys of rats receiving L-NAME and angiotensin II. Kidney International 70 1759-1768. (doi:10.1038/sj.ki.5001897)
20. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J & Wittes J 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. New England Journal of Medicine 341 709-717. (doi:10.1056/NEJM199909023411001)
21. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J & Gatlin M 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine 348 1309-1321. (doi:10.1056/NEJMoa030207)
22. Pojoga LH, Adamová Z, Kumar A, Stennett AK, Romero JR, Adler GK, Williams GH, Khalil R.A. 2010 Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin- 1-deficient mice. American Journal of Physiology. Heart and Circulatory Physiology 298 H1776-H1788.
23. Ricchiuti V, Lian CG, Oestreicher EM, Tran L, Stone JR, Yao T, Seely EW, Williams GH & Adler GK 2009 Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats. Journal of Endocrinology 200 75-84. (doi:10.1677/JOE-08-0199
24. Rocha R, Stier CT Jr, Kifor I, Ochoa-Maya MR, Rennke HG, Williams GH & Adler GK 2000 Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 141 3871-3878. (doi:10.1210/en.141.10.3871)
25. Rocha R, Martin-Berger CL, Yang P, Scherrer R, Delyani J & McMahon E 2002 Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Endocrinology 143 4828-4836. (doi:10.1210/en.2002-220120)
26. Rogacz S, Hollenberg NK & Williams GH 1987 Role of angiotensin II in the hormonal, renal, and electrolyte response to sodium restriction. Hypertension 9 289-294.
27. Schmieder ER, Hilgers FK, Schlaich PM & Schmidt MWB 2007 Renin-angiotensin system and cardiovascular risk. Lancet 369 1208-1219. (doi:10.1016/S0140-6736(07)60242-6)
28. Sharma-Walia N, Naranatt PP, Krishnan HH, Zeng L & Chandran B 2004 Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements. Journal of Virology 78 4207-4223. (doi:10.1128/JVI.78.8.4207-4223.2004)
29. Ushio-Fukai M & Alexander RW 2006 Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle. Hypertension 48 797-803. (doi:10.1161/01.HYP.0000242907.70697.5d)
30. Ushio-Fukai M, Zuo L, Ikeda S, Tojo T, Patrushev NA & Alexander RW 2005 cAbl tyrosine kinase mediates reactive oxygen species- and caveolindependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy. Circulation Research 97 829-836. (doi:10.1161/01. RES.0000185322.46009.F5)
31. Williams GH, Hollenberg NK & Braley LM 1976 Influence of sodium intake on vascular and adrenal angiotensin II receptors. Endocrinology 98 1343-1350. (doi:10.1210/endo-98-6-1343)
32. Zuo L, Ushio-Fukai M, Ikeda S, Hilenski L, Patrushev N & Alexander RW 2005 Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arteriosclerosis, Thrombosis, and Vascular Biology 25 1824-1830. (doi:10.1161/01.ATV. 0000175295.09607.18)